Cabaletta Bio, Inc (CABA) insider trading

Every open-market stock purchase and sale by Cabaletta Bio, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $296K over the last 12 months (8 buys).
  • Last insider buy: Steven Nichtberger (CEO), $101K, 8 months ago.

Last 12 months: insiders bought $296K (8 buys) and sold $0 (0 sales). Last close $3.25 on Jun 4, 2026.

Recent CABA insider trades

DateInsiderTradeValue
Jun 9, 2026Shawn Tomasello (Insider)Bought (not open market)—
Jun 9, 2026Mark Simon (Insider)Bought (not open market)—
Jun 9, 2026Richard C Henriques Jr (Insider)Bought (not open market)—
Jun 9, 2026Catherine Bollard (Insider)Bought (not open market)—
Jun 9, 2026Scott C. Brun (Insider)Bought (not open market)—
Mar 2, 2026Steven Nichtberger (CEO)Bought (not open market)—
Mar 2, 2026Anup Marda (CFO)Bought (not open market)—
Mar 2, 2026Michael Gerard (General Counsel)Bought (not open market)—
Mar 2, 2026Gwendolyn Binder (President)Bought (not open market)—
Mar 2, 2026David J. Chang (C-suite exec)Bought (not open market)—
Mar 2, 2026Arun Das (C-suite exec)Bought (not open market)—
Jan 21, 2026Steven Nichtberger (CEO)Bought$101K
Jan 21, 2026Shawn Tomasello (Insider)Bought$50.3K
Jan 21, 2026Steve Gavel (C-suite exec)Bought$50.2K
Jan 21, 2026Mark Simon (Insider)Bought$25.3K
Jan 21, 2026Gwendolyn Binder (President)Bought$24.8K
Jan 21, 2026David J. Chang (C-suite exec)Bought$19.9K
Jan 21, 2026Michael Gerard (General Counsel)Bought$15K
Jan 21, 2026Catherine Bollard (Insider)Bought$10K
Oct 13, 2025Steve Gavel (C-suite exec)Bought (not open market)—

Who's trading CABA

Get free alerts when an insider at Cabaletta Bio, Inc files a new trade →